Paula Angrand
Family · Bristol, CTNPI 1841660917
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by GSK at 24.4% of the total. 2025 is the largest year on record at $3,004, more than ten times the $45 reported in 2021. Among family clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $25.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$967
- AbbVie$834
- Novo Nordisk$302
- Actelion Pharmaceuticals US, Inc.$198
- Gilead$186
- plus $1K from 29 others
What the payments were for
- Food & beverage$4,79096%
- Education$1754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,965 in reported general payments places this provider in the 90th percentile of 1,596 family providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 32 | $497 |
| CeftriaxoneCeftriaxone Sodium | 12 | $489 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 22 | $392 |
| Levofloxacin | 24 | $288 |
| Pregabalin | 12 | $208 |
| Rosuvastatin Calcium | 11 | $206 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $196 |
| Warfarin Sodium | 34 | $195 |
| Ciprofloxacin Hcl | 13 | $191 |
| Doxycycline Hyclate | 13 | $187 |
| Prednisone | 21 | $125 |
| Torsemide | 14 | $103 |
| Furosemide | 25 | $94 |
| Potassium Chloride | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other family in Bristol
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
- Ralph HirschfeldPutnam$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.